This session will provide a comprehensive look at the initial implementation of the Drug Supply Chain Security Act (DSCSA) in the U.S. and its impact on serialization practices within the pharmaceutical supply chain, highlighting core functionalities such as aggregation and end-to-end traceability across the U.S. market. In this session, you will learn about how to:

• Facilitate seamless data sharing with major U.S. wholesalers to meet DSCSA standards.
• Overcome challenges in serialization and aggregation with industry-driven strategies.
• Enhance traceability and security across the pharmaceutical supply chain.
• Adapt to evolving DSCSA requirements with best practices for compliance and efficiency.

Pharmaceutical track and trace systems have rapidly evolved beyond regulatory compliance tools to become strategic enablers of operational efficiency, supply chain transparency, and product integrity. With increasing complexity in serialization requirements, data integration, and emerging tech applications—from blockchain to AI—the technical demands on serialization infrastructure continue to grow. This panel brings together experts to explore the latest advancements and unresolved technical hurdles in the deployment. Panelists will exchange lessons learned from global rollouts, discuss data architecture evolution, and assess how TrackTS is intersecting with broader digitalization agendas in manufacturing and distribution. The following will be discussed:

• How are companies successfully integrating TrackTS with MES, ERP, and warehouse systems to enable seamless serialization workflows?
• What are the latest approaches for managing and validating vast serialization data across global operations and partners?
• Where are technologies like blockchain and AI proving their worth in serialization, and what are the limits of their current applications?
• As Trackts shifts toward cloud-based models, how are organizations adapting their cybersecurity strategies to ensure system integrity?